Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer

<table>Proposed mechanism for overcoming HNSCC resistance to EGFR antagonists using PI3kinase/Akt/mTOR and NF<i>κ</i>B-IL6-STAT3 pathway inhibitors.</table>

Journal of Oncology

fig1

Figure 1

Figure 1: Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer 